Share

November 2021; 8 (6) Views & ReviewsOpen Access

Remyelination Trials

Are We Expecting the Unexpected?

Alexandr Klistorner, Michael Barnett
First published August 10, 2021, DOI: https://doi.org/10.1212/NXI.0000000000001066
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1125

Share

Article Information

vol. 8 no. 6 e1066
DOI: 
https://doi.org/10.1212/NXI.0000000000001066
PubMed: 
34376551
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received March 20, 2021
  • Accepted in final form June 14, 2021
  • First Published August 10, 2021.
Copyright & Usage: 
Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Alexandr Klistorner, PhD and
    2. Michael Barnett, PhD (michael{at}snac.com.au)
  1. Alexandr Klistorner, PhD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. 1. "Electrophysiological visual field measurement" Klistorner and Graham 1999, PCT/AU99/00340 2. "Method and apparatus for objective electrophysiological assessment of visual function" Klistorner and Graham 2001, PCT/AU01/00423 3. ?Stimulus Method for Multifocal Visual Evoked Potential? Klistorner and Graham (Australian Patent Application No 2007900803) 4. ?Flexible electrode assembly and apparatus for measuring electrophysiological signals? Cheng, Klistorner, Graham (Australian Provisional Patent # 2006904755) 5. ?Apparatus for measuring electrophysiological signals? Cheng, Klistorner, Dyer - Australian Design No. 310666. 6. ? Flexible printed circuit board electrode assembly? Cheng, Klistorner, Dyer - Australian Design No. 311943.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. Sydney University Foundation for Medical Research 2. Sydney eye hospital foundation 3. National MS Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Michael Barnett, PhD (michael{at}snac.com.au)
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) Alexion, Speaker honoraria (2) Novartis, Speaker honoraria (3) Biogen, Speaker honoraria (4) Roche, Speaker honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) RxMx (2) Sydney Neuroimaging Analysis Centre

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Sanofi-Genzyme (2) Bristol Myers Squibb (3) Roche (4) Novartis (5) Biogen (6) Merck

    Research Support, Government Entities:

    1. (1) Australian Government, MRFF Grant, 2021-2024, PI (2) Australian Government, CRC Grant, 2018-2021, PI

    Research Support, Academic Entities:

    1. (1) University of Sydney (2) Sydney Neuroimaging Analysis Centre (3) Royal Prince Alfred Hospital Stock/Stock Options, Medical Equipment & Materials: (1) RxMx (stock), 2015-

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Sydney University (A.K., M.B.); Maquarie University (A.K.); and Sydney Neuroimaging Analysis Center (M.B.), Australia.
  1. Correspondence
    Dr. Klistorner sasha{at}eye.usyd.edu.au

Article usage

Article usage: August 2021 to October 2023

AbstractFullPdfSource
Aug 2021191274177Highwire
Sep 20211243879Highwire
Oct 20212142672Highwire
Nov 2021318054Highwire
Dec 202189126Highwire
Jan 2022311851Highwire
Feb 2022720433Highwire
Mar 2022528955Highwire
Apr 2022320045Highwire
May 2022123337Highwire
Jun 2022819642Highwire
Jul 2022022715Highwire
Aug 2022427131Highwire
Sep 2022528334Highwire
Oct 2022429426Highwire
Nov 20221034845Highwire
Dec 2022322729Highwire
Jan 2023531923Highwire
Feb 20231342635Highwire
Mar 2023542734Highwire
Apr 2023231329Highwire
May 2023529940Highwire
Jun 2023427722Highwire
Jul 20231227835Highwire
Aug 2023630626Highwire
Sep 2023323111Highwire
Oct 2023217119Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles